Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 15:12:924119.
doi: 10.3389/fcimb.2022.924119. eCollection 2022.

The Complex Link and Disease Between the Gut Microbiome and the Immune System in Infants

Affiliations
Review

The Complex Link and Disease Between the Gut Microbiome and the Immune System in Infants

Huan Zhang et al. Front Cell Infect Microbiol. .

Abstract

The human gut microbiome is important for human health. The development of stable microbial communities in the gastrointestinal tract is closely related to the early growth and development of host immunity. After the birth of a baby, immune cells and the gut microbiome mature in parallel to adapt to the complex gut environment. The gut microbiome is closely linked to the immune system and influences each other. This interaction is associated with various diseases in infants and young children, such as asthma, food allergies, necrotizing colitis, obesity, and inflammatory bowel disease. Thus, the composition of the infant gut microbiome can predict the risk of disease development and progression. At the same time, the composition of the infant gut microbiome can be regulated in many ways and can be used to prevent and treat disease in infants by modulating the composition of the infant gut microbiome. The most important impacts on infant gut microbiota are maternal, including food delivery and feeding. The differences in the gut microbiota of infants reflect the maternal gut microbiota, which in turn reflects the gut microbiota of a given population, which is clinically significant.

Keywords: diseases; immune; infant; maturation; microbiome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Commensals and pathogens produce different immune responses. PRRs identify MAMPs on pathogens and symbionts and are extensively expressed in intestinal epithelial cells, macrophages, and dendritic cells. Dendritic cells offer antigens to naive T cells as a result of commensals, and these cells differentiate into Treg cells, which emit anti-inflammatory cytokines and spread systemic and local tolerance. Simultaneously, phagocyte migration is inhibited, allowing microbial antigens to reach lymphoid tissue and increasing B- and T-cell activation. Conversely, pathogenic germs cause dendritic cells to secrete pro-inflammatory cytokines, which cause naive T cells to differentiate into Th1 and Th17 cells, resulting in a pro-inflammatory immune response. (Created in BioRender.com).

References

    1. Abdel-Aziz M. I., Vijverberg S. J. H., Neerincx A. H., Kraneveld A. D., Maitland-van der Zee A. H. (2019). The Crosstalk Between Microbiome and Asthma: Exploring Associations and Challenges. Clin. Exp. Allergy 49 (8), 1067–1086. doi: 10.1111/cea.13444 - DOI - PMC - PubMed
    1. Akkerman R., Faas M. M., de Vos P. (2019). Non-Digestible Carbohydrates in Infant Formula as Substitution for Human Milk Oligosaccharide Functions: Effects on Microbiota and Gut Maturation. Crit. Rev. Food Sci. Nutr. 59 (9), 1486–1497. doi: 10.1080/10408398.2017.1414030 - DOI - PubMed
    1. Algert C. S., McElduff A., Morris J. M., Roberts C. L. (2009). Perinatal Risk Factors for Early Onset of Type 1 Diabetes in a 2000-2005 Birth Cohort. Diabetes Med. 26 (12), 1193–1197. doi: 10.1111/j.1464-5491.2009.02878.x - DOI - PMC - PubMed
    1. Allen J. E., Maizels R. M. (2011). Diversity and Dialogue in Immunity to Helminths. Nat. Rev. Immunol. 11 (6), 375–388. doi: 10.1038/nri2992 - DOI - PubMed
    1. Armanian A. M., Sadeghnia A., Hoseinzadeh M., Mirlohi M., Feizi A., Salehimehr N., et al. (2014). The Effect of Neutral Oligosaccharides on Reducing the Incidence of Necrotizing Enterocolitis in Preterm Infants: A Randomized Clinical Trial. Int. J. Prev. Med. 5 (11), 1387–1395. doi: 10.4103/2279-042X.176558 - DOI - PMC - PubMed

Publication types

LinkOut - more resources